BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.72 EUR
-2.16%
Updated:
May 7, 2024
BRAIN Biotech AG
Cash from Investing Activities
|
BRAIN Biotech AG
Cash from Investing Activities Peer Comparison
Comparables:
WCH
EVK
1COV
ACT
SY1
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BRAIN Biotech AG
XETRA:BNN
|
Cash from Investing Activities
-€2.2m
|
CAGR 3-Years
23%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Wacker Chemie AG
XETRA:WCH
|
Cash from Investing Activities
-€107.6m
|
CAGR 3-Years
48%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
|
Evonik Industries AG
XETRA:EVK
|
Cash from Investing Activities
-€653m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Covestro AG
XETRA:1COV
|
Cash from Investing Activities
-€925m
|
CAGR 3-Years
19%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
AlzChem Group AG
XETRA:ACT
|
Cash from Investing Activities
-€20.5m
|
CAGR 3-Years
11%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Symrise AG
XETRA:SY1
|
Cash from Investing Activities
-€358.3m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-15%
|
See Also
What is BRAIN Biotech AG's Cash from Investing Activities?
Cash from Investing Activities
-2.2m
EUR
-2.2m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Cash from Investing Activities amounts to -2.2m EUR.
What is BRAIN Biotech AG's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
11%
11%
Over the last year, the Cash from Investing Activities growth was 75%. The average annual Cash from Investing Activities growth rates for BRAIN Biotech AG have been 23% over the past three years , 11% over the past five years .
You don't have any saved screeners yet
